Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Immunosuppressant Treatment Without Corticosteroids After First Renal Transplant
NCT00200551Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Jan 2001
- Primary completion
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil and cyclosporine in renal transplant rejection (RTR) (2 arms), sponsored by CHU de Nantes. Primary endpoint: Number of acute rejection episodes at 1 year. Started Jan 2001; status: completed.
02
Drugs
mycophenolate mofetilcyclosporine
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT00200551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200551.